Home | Site map | Contact us
Change type size:  A | A

Clients

Press releases

For more information or background, contact our press officers:

Liz Wyatt or Richard Anderson
DeFacto Communications Ltd
Tel: +44 (0)20 7861 3838

Press releases:

Archived press releases

2007
2006
2005
2004
2003

13/08/08 - Eden Biodesign signs Marketing Services Agreement with Human Genome Sciences (click to download pdf or see text below)

17/06/08 - Eden Biodesign Inc. confirms Research Triangle Park Facility

06/06/08 - Eden Biodesign advances toward establishing its U.S Operation

06/03/08 - Eden Biodesign and Stealthyx Therapeutics Ltd sign deal to develop enhanced treatment for Rheumatoid Arthritis

31/01/08 - Eden Biodesign and iQur sign deal to develop a novel combine vaccine for treatment of Hepatitis A & B 

Background:

Who is Eden Biodesign?

What is the National Biomanufacturing Centre?

Latest press release:

EDEN BIODESIGN SIGNS MARKETING SERVICES AGREEMENT WITH HUMAN GENOME SCIENCES

New alliance will increase Human Genome Sciences’ global marketing reach for large scale cGMP manufacturing services and provides a seamless range of services for clients from process development to 20,000L scale production

Liverpool, UK; and Research Triangle Park, NC USA - 13 August 2008

Eden Biodesign Ltd., an expert provider of biopharmaceutical process development and cGMP manufacturing services today announced that they have entered into a marketing services agreement with Human Genome Sciences, Inc. (Nasdaq: HGSI, Rockville, MD).

Under the terms of the agreement, Eden Biodesign will use its expertise and global presence in the biopharmaceutical contract manufacturing market to assist HGS in identifying new manufacturing clients for their large scale commercial cell culture production facilities located in Rockville, MD. Both companies will use their combined expertise in process development, process scale-up, technology transfer, analytical and international regulatory support for biopharmaceuticals to provide customers with rapid and cost-effective transition into cGMP manufacturing at scales up to 20,000L and seamless access to commercial production capacity for biopharmaceuticals derived from mammalian cell culture.

“This alliance is particularly significant for Eden Biodesign and we are delighted that such a prestigious company as Human Genome Sciences has recognized Eden Biodesign’s technical excellence, global marketing reach and strong track record” commented Dr. Crawford Brown, Chief Executive Officer of Eden Biodesign. “In addition to our process development and clinical scale cGMP production services, our growing portfolio of successful clients may now also have seamless access to Human Genome Science’s world leading expertise in late-stage process development and state-of-the-art large scale production facilities as their products progress towards and into commercial launch”.

Eden Biodesign provides clients with a wide range of process development and cGMP manufacturing services for all major product categories from EMEA inspected facilities in Liverpool, UK. The company’s consulting arm offers global CMC support, cGMP training and a range of support services designed to accelerate clinical development and product launch.

Curran Simpson, Senior Vice President of Operations, HGS, said: “Eden Biodesign’s international business development presence and biopharmaceutical manufacturing expertise make them a partner of choice. Eden shares our commitment to technical excellence and brings considerable international regulatory experience and a proven history in biopharmaceutical development to our relationship”.

Ends

Our clients are the business. It is imperative they get value